HLS Therapeutics has the go ahead from the Toronto Stock Exchange to buy back up to 6.9% of its public float of shares over the next 12 months. The Canadian pharmaceutical company said Thursday it ...

The late-stage biopharma said the plan will issue one right for each share of common stock as of the close of business on March 24. The rights will initially trade with its common stock, and will ...

The American Association of Individual Investors' weekly survey on investors' sentiment has been getting a lot of attention lately, given just how bearish participants' sentiment has become. The ...

AtkinsRealis renewed a share buyback program and reached a deal to bring in up to 2.79 billion Canadian dollars ($1.94 billion) exiting its remaining stake in a toll highway that runs through Toronto.

Ballard Power Systems reported a narrowed loss in the fourth quarter as the hydrogen and fuel cell industry faces strong headwinds, reducing its revenue generation in the period.

Certain stocks are likely to lose money, even if the U.S. stock market stops declining and starts rising again.

Transat A.T. reported a wider first-quarter loss, despite higher revenue. The Canadian integrated tour operator's loss deepened to 122.5 million Canadian dollars ($85.3 million), or C$3.10 a share, ...

Build-A-Bear's fiscal 2024 fourth quarter consisted of a 13-week period, while its fourth quarter in 2023 comprised a 14-week period. For fiscal 2025, Build-A-Bear expects revenue to grow on a ...

Stocks come with higher investment risk, of course; that’s why their rewards are greater. But U.S. investors should ...

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S.

Recent months - before the latest sell-off - have shown that the market as a whole can advance despite weakness from some of the mega tech names. But struggles for the likes of Microsoft, which still ...